31% growth masks 0.5% quarter — RACL holds the line on guidance

The headline tells one story: 31.5% year-over-year revenue growth, the kind of number that shows up in investor presentations as proof of momentum. But the quarter itself tells another. Sequential growth of just 0.5%—near-flat—combined with net profit down 27.9% quarter-over-quarter, signals that Q1 was a weak quarter inside a strong year. The market saw it first: the stock fell 6.4% on day 1 of the announcement and held losses through day 5 (−6.25%), a verdict that tracked with management's own caution.

Profit grew 7.7% while revenue grew 31.5%. Three factors explain the gap. First: tax. Q1 tax rate was 47%, well above the full-year target of 25.62%, due to a surcharge rate change affecting deferred tax calculations—a one-time impact that depressed reported PAT by roughly ₹1–2 Cr. Second: cost inflation. Raw materials are reflected at 28% of revenue, but this includes a stock-in-transit timing benefit; historical RM ran 30–33%, suggesting underlying cost pressure. Third: operating expense absorption, which may not have scaled proportionally with revenue. The upshot: organic profit growth is materially softer than the headline 7.7% suggests.

Three material updates from the call. First: KTM recovery confirmed. The Austrian subsidiary's customer, KTM Bikes, has stabilized post-insolvency. New models (Duke 790, etc.) are launching; management flagged 'good forecast' for coming months. No revenue uplift visible in Q1, but narrative upgraded from 'in recovery' to 'bounced back to pre-COVID levels or slightly above.' Second: Royal Enfield empanelment progressing. Commercial supplies began in January 2026 for a 350 CC motorcycle transmission. Current run-rate is 7.5–8,000 units/month; target is 10,000/month. Multi-model pipeline under development (confidential). Third: BMW Project Venus de-risked. Level 1 approval complete, pilot supplies in transit or already at customer; final approvals scheduled for October 24. This is the company's sole-source opportunity on a major OEM platform.

Guidance held despite all three catalysts. Analysts asked repeatedly whether KTM + Royal Enfield + BMW warranted an upward revision to FY27 guidance (currently 565±5% Cr). Management declined and explicitly held the range. Rationale offered: customers not growing >20% organically, RACL's share <20% per customer, and mid-year revisions 'inappropriate.' This restraint is credible, but it is also a subtle signal that management lacks visibility into these ramps accelerating materially in FY27. Expect Q2–Q4 to need significant acceleration to hit the mid-point.

The market's post-result reaction is the clearest signal. On announcement day (August 7), the stock fell 6.4% with 56.6% delivery volume—indicating real selling, not noise. The decline held through day 5 (−6.25%), a vote that the market saw past the YoY headline and shared management's caution. The stock is now 9.1% off its all-time high of ₹1,691.9, trading at ₹1,537.9, but still up 66.84% off its 52-week low (₹921.8). Technically, RSI is at 70.2 (overbought), suggesting mean-reversion risk if momentum stalls further. On flows: FII ownership ticked down 0.28 percentage points QoQ to 9.26% (Q1 FY27), while DII held flat at 3.23% and promoter ticked up marginally to 42.70%. The FII trim is modest but directional—institutions are not aggressively rotating into the stock. The street's posture: cautiously skeptical, waiting for catalysts (BMW final approval, Q2 acceleration) to prove out.